Announcements Trials
Browse Landscape

Phase

Phase NA 30Phase 2 8Phase 4 6Phase 3 3Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 13Unknown 6Recruiting 6Active not recruiting 6Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Papillomavirus Infections × Clear all
NCT05334706 2026-02-23

RIFT-HPV

Institut d'Investigació Biomèdica de Bellvitge

Phase 4 Recruiting
69 enrolled
Gynecologic

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

Precigen, Inc

Phase 4 Recruiting
30 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT07281677 2025-12-15

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

Zhejiang Provincial Center for Disease Control and Prevention

Phase 4 Recruiting
400 enrolled

Papillomavirus Infections

NCT05672927 2025-10-06

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

The University of Texas Medical Branch, Galveston

Phase 4 Recruiting
618 enrolled

Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT04910802 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Region Stockholm

Phase 4 Recruiting
150,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡